Navigation Links
Research explains link between cholesterol and heart disease
Date:9/18/2007

Cholesterol contributes to atherosclerosis a condition that greatly increases the risk of heart attack and stroke by suppressing the activity of a key protein that protects the heart and blood vessels, researchers at the Saint Louis University School of Medicine have found.

Their findings could lead to new therapies to treat or prevent heart disease the leading cause of death in the United States as well as answer key questions about other diseases associated with high cholesterol levels, including some types of cancer.

The study is published in an early online edition of the Journal of Cell Science (http://jcs.biologists.org).

We believe these findings represent a significant and novel breakthrough in cardiovascular research, said Jung San Huang, Ph.D., professor of biochemistry and molecular biology at the Saint Louis University School of Medicine and the studys lead researcher.

This study gives us new insight into how cholesterol promotes atherosclerosis and in turn, how it leads to heart attack and stroke, Dr. Huang added. This could give us important new tools in the fight against heart disease.

It has long been known that high blood cholesterol is a key risk factor for developing atherosclerosis sometimes called hardening of the arteries. The condition causes the arteries of the heart and other tissues to become damaged and narrowed, preventing blood from pumping through as it should and increasing the risk of heart attack and stroke.

Until now, however, the process by which cholesterol contributes to atherosclerosis has not been well understood.

Using an animal model, Chun-Lin Chen, a senior graduate student on Dr. Huangs research team, found that cholesterol limits the activity of a key protective protein called transforming growth factor-beta (TGF-beta). TGF-beta serves many important functions in the body; in the heart, it protects the aorta and other vessels from damage caused by a variety of factors, including hypertension and high blood cholesterol levels.

Cholesterol, however, suppresses the responsiveness of cardiovascular cells to TGF-beta and its protective qualities thus allowing atherosclerosis to develop. Similarly, the research found that statins, drugs that lower cholesterol levels, enhance the responsiveness of cardiovascular cells to the protective actions of TGF-beta, thus helping prevent the development of atherosclerosis and heart disease.

Dr. Huang believes that this research could lead to the development of novel and effective therapies to treat or prevent atherosclerosis.

For example, drugs that enhance or promote the protective activity of TGF-beta in cardiovascular cells should be effective in treating or preventing atherosclerosis, alone or in combination with other cholesterol-lowering agents.

In addition, the findings also suggest answers to questions about other diseases associated with high blood cholesterol levels, including cancer. For example, why are patients with high cholesterol also prone to develop cancer" And why does drug therapy to lower blood cholesterol correlate with a lower incidence of some cancers, as has been previously reported"

TGF-beta, it turns out, is a well- known tumor suppressor, and loss of TGF-betas protective effects caused by high blood cholesterol could thus increase formation of these cancers, the findings suggest.

We believe the effects of our research could be far-reaching and of great interest to the pharmaceutical, academic and clinical communities, Dr. Huang said.


'/>"/>

Contact: Donn Walker
dwalke18@slu.edu
314-977-8015
Saint Louis University
Source:Eurekalert

Related biology news :

1. Researchers discover way to make cells in the eye sensitive to light
2. Quantum Dots Research Leads to New Knowledge about Protein Binding in Plants
3. Columbia research lifts major hurdle to gene therapy for cancer
4. Researchers find how protein allows insects to detect and respond to pheromones
5. Researchers Uncover Key Step In Manufacture of Memory Protein
6. Research advances quest for HIV-1 vaccine
7. Research on Worms Yields Clues on Aging
8. U of M researcher examines newly emerging deadly disease
9. NYU researchers simulate molecular biological clock
10. Researchers reveal the infectious impact of salmon farms on wild salmon
11. Researchers identify target for cancer drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... and PUNE, India , January 12, 2017 ... Opportunities and Forecasts, 2015 - 2022," projects that the global biometric technology market is ... 19.4% from 2016 to 2022. Continue Reading ... ... ...
(Date:1/6/2017)... , Jan. 5, 2017  SomaLogic announced ... "Digital Life Alliance" established by iCarbonX, the ... to build a "Global Digital Health Ecosystem that ... a combination of individual,s biological, behavioral and psychological ... agreement between the companies, SomaLogic will provide proteomics ...
(Date:1/3/2017)... Jan. 3, 2017 Onitor, provider of digital ... Onitor Track, an innovative biometric data-driven program designed to ... month at the 2017 Consumer Electronics Show (CES) in ... In the U.S., the World Health Organization (WHO), have ... of adults who are overweight or obese. WHO also ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... and GAITHERSBURG, Md. ... MKT: PIP) and Altimmune, Inc., a privately-held immunotherapeutics ... of a definitive agreement for the merger of ... current investors include Novartis Venture Fund, HealthCap, Truffle ... be a fully-integrated and diversified immunotherapeutics company with ...
(Date:1/19/2017)... 2017 AquaBounty Technologies, Inc. (AIM: ABTU; NASDAQ: ... aquaculture and a majority-owned subsidiary of Intrexon Corporation (NYSE: ... the listing of its common shares on the NASDAQ ... "AquaBounty,s listing on NASDAQ represents an important ... to the U.S. markets as we advance plans for ...
(Date:1/19/2017)... ... 18, 2017 , ... LabRoots , the leading provider ... world, was today awarded the "Best Science & Technology Social Networking Service 2016" ... decided upon by a dedicated team of researchers and analysts. , The 2016 ...
(Date:1/19/2017)... ... 2017 , ... DaVita Clinical Research (DCR), a ... device development, and Prism Clinical Research , a leader in providing fully ... Clinical Trials (VCT) has been selected by both companies as an exclusive ...
Breaking Biology Technology: